The antihyperlipidemic effects of fullerenol nanoparticles via adjusting the gut microbiota in vivo

BACKGROUND: Nanoparticles (NPs) administered orally will meet the gut microbiota, but their impacts on microbiota homeostasis and the consequent physiological relevance remain largely unknown. Here, we describe the modulatory effects and the consequent pharmacological outputs of two orally administe...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Juan, Lei, Runhong, Li, Xin, Xiong, Fengxia, Zhang, Quanyang, Zhou, Yue, Yang, Shengmei, Chang, Yanan, Chen, Kui, Gu, Weihong, Wu, Chongming, Xing, Gengmei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5773151/
https://www.ncbi.nlm.nih.gov/pubmed/29343276
http://dx.doi.org/10.1186/s12989-018-0241-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5773151/
https://www.ncbi.nlm.nih.gov/pubmed/29343276
http://dx.doi.org/10.1186/s12989-018-0241-9

Ejemplares similares